Objectives: Between 20 000 and 35 000 cases of salmonellosis are detected annually in Germany, but only a few Salmonella are resistant to third-generation cephalosporins. The German National Reference Centre for Salmonella and other Enterics obtained 150 Salmonella enterica isolates from human infections between 2005 and 2011. In the present study we identified the b-lactamase genes causing resistance to third-generation cephalosporins in these isolates.
Introduction
Salmonella enterica is a widespread cause of foodborne gastrointestinal infections in Europe, with S. enterica Typhimurium and S. enterica Enteritidis as the most common serovars. 1 According to official national statistics, 24454 cases of salmonellosis were reported in Germany in 2011. In recent years the number of reports on emergence of multidrug-resistant S. enterica from humans and animals, especially with resistance to extendedspectrum cephalosporins such as ceftazidime and cefotaxime, has increased worldwide. 2 -4 Resistance to cephalosporins is mainly due to acquisition of genes encoding extended-spectrum b-lactamases (ESBLs) or AmpC b-lactamases. These b-lactamase genes are mainly plasmid-encoded and transferable into other enterobacterial species. The aim of the present study was the identification of b-lactamases causing resistance to third-generation cephalosporins in S. enterica isolates from humans.
Materials and methods
The National Reference Centre (NRC) for 7 were performed. Confirmation of the monophasic variant of Salmonella Typhimurium strains was done by PCR amplification of the fljB flagellar gene. 8 All 150 isolates, being resistant to cefotaxime and/or ceftazidime, were tested for ESBL or AmpC production by disc tests (AMPC+ ESBL DETECTION SET D68C, MAST Group).
The presence of b-lactamase genes was tested by PCR amplification and sequencing of ESBL genes bla TEM-type , bla SHV-type and bla CTX-M-1/2/ 9-type 9,10 and plasmid-mediated ampC genes. 11 The presence of ESBL genes bla CTX-M-8-type and bla CTX-M-25-type was tested using primers
The ampC genes bla CMY-type and bla ACC-type were sequenced using the primers CMY-FWD (5 ′ -TCTGCTGCTGACAGCCTCT-3 ′ ) and CMY-REV (5 ′ -CTC GACACGGACAGGGTTAG-3 ′ ), and ACC-FWD (5 ′ -TACCTGTCTGGCAGCAA CTG-3 ′ ) and ACC-REV (5 ′ -TTTTATACGCCACCGTCACTC-3 ′ ), respectively. In isolates with MICs of ciprofloxacin of 0.125 to .64 mg/L the presence of plasmid-mediated quinolone resistance (PMQR) genes [qnr-type genes and aac(6 ′ )1b-cr] was determined. 10, 12 Genetic relatedness was determined by XbaI macrorestriction analysis followed by PFGE with interpretation according to the criteria of Tenover et al. 13 Plasmids of selected isolates were transferred by broth mate conjugation into a sodium azide-resistant Escherichia coli K12J53 recipient. 10 Plasmids were characterized using S1 nuclease restriction of genomic DNA and subsequent PFGE 14 as well as PCR-based replicon typing. 15 
Results and discussion
Within the period of 7 years (2005 -11) we found 150 S. enterica isolates that were resistant to third-generation cephalosporins (average of 22 isolates/year). The most frequent of the 30 determined serovars among these 150 isolates were Salmonella Typhimurium (n¼73; 48.7%), including 23 monophasic isolates 4, [5] ,12:i:- (Table 1) , followed by Salmonella Infantis (n¼ 11; 7.3%), Salmonella Enteritidis (n¼ 7; 4.7%) and Salmonella Kentucky (n ¼6; 4.0%). The mean rate of resistance to cefotaxime and/or ceftazidime was 0.6%, with a slight but not significant (P ¼ 0.181; correlation coefficient 0.523; Spearman rank correlation) increase from 2005 (0.36%) to 2011 (0.84%). Furthermore, 17 of the 150 isolates showed a combined resistance to ampicillin, chloramphenicol and trimethoprim/sulfamethoxazole (Table S1 , available as Supplementary data at JAC Online) and 13 isolates showed an additional resistance to ciprofloxacin.
By PCR and sequencing we confirmed the presence of various ESBL and AmpC b-lactamase genes ( Table 2 ). The most prevalent gene was bla CTX-M-1 (n¼ 91; 60.7%), followed by bla CTX-M-14 (n¼ 12; 8.0%) and bla SHV-12 (n¼ 11; 7.3%). In six isolates bla CTX-M-15 was present and single isolates were positive for bla CTX-M-2 , bla CTX-M-3 and bla CTX-M-8 (Table 2 ). The AmpC b-lactamase genes bla CMY-2 and bla ACC-1 were found in eight isolates (seven different
The XbaI macrorestriction analysis revealed identical macrorestriction patterns, indicating a prolonged transmission of an ACC-1-positive Salmonella Bareilly strain in 2005 and the nationwide dissemination of a CTX-M-1-producing Salmonella Typhimurium clone of phage type DT193 (22 isolates) in 2007. Furthermore, we observed the repeated occurrence of ESBL-positive strains of Salmonella Anatum (two isolates), Salmonella Kentucky (four isolates) Salmonella Kapemba (two isolates) and Salmonella Infantis (four isolates).
The 22 isolates of the CTX-M-1-producing Salmonella Typhimurium DT193 clone were received from different hospitals in five German federal states in 2007. We ask the Federal Institute for Risk Assessment in Berlin to send us isolates from livestock that emerged in 2007 and harboured identical ESBLs. By comparative macrorestriction analysis of the Salmonella Typhimurium isolates, we identified this Salmonella Typhimurium DT193 clone again in three faecal specimens from pigs isolated in 2006. The Salmonella Typhimurium DT193 clone contained CTX-M-1 ESBL and the TEM-1 b-lactamase. Subsequent plasmid analysis revealed genes bla CTX-M-1 and bla TEM-1 , located on two conjugative plasmids ( 35 and 120 kb) belonging to replicon types IncN and IncFII, respectively.
By comparative analyses of further ESBL-producing Salmonella strains from humans and livestock we identified two strains of Salmonella Infantis carrying bla TEM-52 (IncI1 plasmid, 80 kb) and bla CTX-M-1 (IncI1 plasmid, 100 kb), respectively. Each of these isolates was genetically identical (PFGE and plasmid analysis) to an isolate from a chicken, found in the same period of time. In addition, the only human Salmonella Paratyphi B d-tartrate-positive (dT+) strain of the present study that carried bla TEM-52 (IncI1 Total  -2  2  3  3  4  9  2 3 RDNC, reacts but does not conform with any phage type.
ESBLs and AmpC b-lactamases in Salmonella, Germany 1979 JAC plasmid, 80 kb) showed an XbaI macrorestriction pattern identical to those of four TEM-52-producing Salmonella Paratyphi B (dT+) isolates from poultry. Our study data demonstrate that the majority (48.7%) of ESBLand AmpC-producing human S. enterica isolates were Salmonella Typhimurium, which represents one of the most common serotypes in Europe.
1 Among these Salmonella Typhimurium we identified 23 (31.5%) isolates as the monophasic variant 4, [5] ,12:i:-. Monophasic Salmonella Typhimurium carrying ESBLs were recently reported from livestock. 16 The high percentage of ESBL-positive monophasic strains could result from the generally increasing number of monophasic Salmonella Typhimurium according to the data from the NRC database in Germany (n¼ 82 in 2005 to n¼ 621 in 2011) and all over Europe. 17 Furthermore, the present study showed that the majority of strains harboured bla CTX-M -like enzymes (n¼ 116; 77.3%) with CTX-M-1 as the most prevalent ESBL type in human S. enterica isolates; similar results were found in Salmonella and E. coli from animals, especially poultry. 18, 19 Moreover, detailed molecular analyses revealed the emergence of partly the same plasmid-encoded ESBL and AmpC types (e.g. CTX-M-1, TEM-52 and CMY-2) as described in a previous study of S. enterica isolates from German livestock animals. 18 In contrast, ESBL type CTX-M-15, which is highly prevalent in human nosocomial E. coli, 20 was identified only in six human S. enterica isolates, including a Salmonella Typhi isolate from a patient from abroad. 10 The comparison of the present results with international data confirmed that CTX-M-1 ESBL and CMY-2 AmpC are prevalent enzymes in third-generation-cephalosporin-resistant Salmonella worldwide. 21 In Spain bla CTX-M-1 was recently described on IncI1/N plasmids (100 kb), indicating a possible transnational spread of resistant Salmonella clones or plasmids. Eller et al.
